Literature DB >> 28899258

Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database.

Kathy K Byrd1, Tim Bush1, Lytt I Gardner1.   

Abstract

The significance of a gap in HIV care depends, at least partially, on whether patients continue to fill prescriptions for antiretroviral (ARV) drugs during the gap in care. We used a billing claims database to determine the proportion of persons who filled ≥1 prescription for ARV drugs during a gap in care (no clinic visit in >6 months). Persons were stratified into 3 groups: "never" (prescriptions never filled), "sometimes" (prescriptions filled >0%-<100% of months), and "always" (prescriptions filled monthly). Logistic regression analyses were conducted to determine factors associated with "never" filling ARV drugs. Of 14 308 persons, 69% (n = 9817), 13% (n = 1928), and 18% (n = 2563) "never," "sometimes," and "always" filled ARV drugs during the gap in care. Persons aged 18 to 29 years (odds ratio [OR] = 1.56, 95% confidence interval [CI] 1.39-1.74), women (OR = 1.67, CI 1.52-1.83), and persons from the Northeast region of the United States (OR = 1.86, CI 1.69-2.03) were more likely to never fill ARV drugs than persons aged ≥30 years, men, and persons outside the Northeast, respectively. Efforts should be made to minimize gaps in care, emphasize importance of therapy, and provide adherence support.

Entities:  

Keywords:  AIDS; HIV; adherence; antiretroviral therapy; health care

Mesh:

Substances:

Year:  2017        PMID: 28899258      PMCID: PMC6195762          DOI: 10.1177/2325957417729750

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  37 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

3.  Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).

Authors:  Shilpa Viswanathan; Roger Detels; Shruti H Mehta; Bernard J C Macatangay; Gregory D Kirk; Lisa P Jacobson
Journal:  AIDS Behav       Date:  2015-04

4.  Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV.

Authors:  Sannisha K Dale; Laura M Bogart; Glenn J Wagner; Frank H Galvan; David J Klein
Journal:  J Health Psychol       Date:  2014-10-07

5.  Impact of age on retention in care and viral suppression.

Authors:  Baligh R Yehia; Peter Rebeiro; Keri N Althoff; Allison L Agwu; Michael A Horberg; Hasina Samji; Sonia Napravnik; Kenneth Mayer; Ellen Tedaldi; Michael J Silverberg; Jennifer E Thorne; Ann N Burchell; Sean B Rourke; Anita Rachlis; Angel Mayor; Michael J Gill; Anne Zinski; Michael Ohl; Kathryn Anastos; Alison G Abraham; Mari M Kitahata; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

6.  Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.

Authors:  Jessica E Haberer; Nicholas Musinguzi; Yap Boum; Mark J Siedner; A Rain Mocello; Peter W Hunt; Jeffrey N Martin; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

7.  Disparities in the quality of HIV care when using US Department of Health and Human Services indicators.

Authors:  Keri N Althoff; Peter Rebeiro; John T Brooks; Kate Buchacz; Kelly Gebo; Jeffrey Martin; Robert Hogg; Jennifer E Thorne; Marina Klein; M John Gill; Timothy R Sterling; Baligh Yehia; Michael J Silverberg; Heidi Crane; Amy C Justice; Stephen J Gange; Richard Moore; Mari M Kitahata; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

8.  Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes.

Authors:  Heather Bradley; Abigail H Viall; Pascale M Wortley; Antigone Dempsey; Heather Hauck; Jacek Skarbinski
Journal:  Clin Infect Dis       Date:  2015-08-30       Impact factor: 9.079

9.  Improving medication adherence with a targeted, technology-driven disease management intervention.

Authors:  David B Lawrence; Wanda Allison; Joyce C Chen; Michael Demand
Journal:  Dis Manag       Date:  2008-06

Review 10.  Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis.

Authors:  Ingrid T Katz; Annemarie E Ryu; Afiachukwu G Onuegbu; Christina Psaros; Sheri D Weiser; David R Bangsberg; Alexander C Tsai
Journal:  J Int AIDS Soc       Date:  2013-11-13       Impact factor: 5.396

View more
  2 in total

1.  Gaps Up To 9 Months Between HIV Primary Care Visits Do Not Worsen Viral Load.

Authors:  Lytt I Gardner; Gary Marks; Unnati Patel; Edward Cachay; Tracey E Wilson; Michael Stirratt; Allan Rodriguez; Meg Sullivan; Jeanne C Keruly; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2018-04       Impact factor: 5.078

2.  Life Chaos is Associated with Reduced HIV Testing, Engagement in Care, and ART Adherence Among Cisgender Men and Transgender Women upon Entry into Jail.

Authors:  Sae Takada; Susan L Ettner; Nina T Harawa; Wendy H Garland; Steve J Shoptaw; William E Cunningham
Journal:  AIDS Behav       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.